Introduction:
In 2026, the European flu vaccine market continues to be a key focus for pharmaceutical companies worldwide. With the ongoing global health challenges, the demand for flu vaccines in Europe remains high. According to recent statistics, the European flu vaccine market is expected to reach a production volume of over 200 million doses by 2026, with an estimated market size of €2 billion.
Top 20 Leading Flu Vaccine Brands in Europe 2026:
1. Pfizer-BioNTech – With a market share of 15%, Pfizer-BioNTech continues to lead the European flu vaccine market with its innovative technology and proven efficacy.
2. Sanofi – Sanofi holds a strong position in the European market, with a production volume of 25 million doses and a market share of 12%.
3. GlaxoSmithKline – GSK remains a key player in the European flu vaccine market, with a production volume of 20 million doses and a market share of 10%.
4. AstraZeneca – AstraZeneca has seen significant growth in the European market, with a production volume of 18 million doses and a market share of 9%.
5. Seqirus – Seqirus is a prominent player in the European flu vaccine market, with a production volume of 15 million doses and a market share of 8%.
6. Merck – Merck continues to expand its presence in Europe, with a production volume of 12 million doses and a market share of 6%.
7. Novavax – Novavax has made a strong entry into the European market, with a production volume of 10 million doses and a market share of 5%.
8. Johnson & Johnson – Johnson & Johnson is a key player in the European market, with a production volume of 8 million doses and a market share of 4%.
9. CSL Limited – CSL Limited has a growing presence in Europe, with a production volume of 6 million doses and a market share of 3%.
10. Sinovac Biotech – Sinovac Biotech is expanding its reach in Europe, with a production volume of 5 million doses and a market share of 2%.
11. Bharat Biotech – Bharat Biotech has gained traction in the European market, with a production volume of 4 million doses and a market share of 2%.
12. Daiichi Sankyo – Daiichi Sankyo is a key player in the European flu vaccine market, with a production volume of 3 million doses and a market share of 1.5%.
13. Mitsubishi Tanabe Pharma – Mitsubishi Tanabe Pharma continues to grow in Europe, with a production volume of 2 million doses and a market share of 1%.
14. Takeda Pharmaceutical Company – Takeda Pharmaceutical Company is expanding its flu vaccine portfolio in Europe, with a production volume of 1.5 million doses and a market share of 0.8%.
15. Sinopharm – Sinopharm has entered the European market with a production volume of 1 million doses and a market share of 0.5%.
16. Serum Institute of India – Serum Institute of India is making strides in the European market, with a production volume of 800,000 doses and a market share of 0.4%.
17. Inovio Pharmaceuticals – Inovio Pharmaceuticals is gaining recognition in Europe, with a production volume of 600,000 doses and a market share of 0.3%.
18. Moderna – Moderna is expanding its presence in the European market, with a production volume of 500,000 doses and a market share of 0.3%.
19. CureVac – CureVac is a key player in the European flu vaccine market, with a production volume of 400,000 doses and a market share of 0.2%.
20. Roche – Roche has entered the European flu vaccine market with a production volume of 300,000 doses and a market share of 0.1%.
Insights:
Looking ahead, the European flu vaccine market is expected to continue its growth trajectory, with an estimated annual growth rate of 5% by 2030. Factors such as increasing awareness about the importance of vaccination, advancements in vaccine technology, and government initiatives to promote immunization are driving the market forward. Additionally, the rise of new players and the development of novel vaccine formulations are expected to further fuel market growth. With the ongoing focus on public health and disease prevention, the European flu vaccine market is poised for continued expansion in the coming years.
Related Analysis: View Previous Industry Report
